Glycan susceptibility factors in autism spectrum disorders
- PMID: 27418189
- PMCID: PMC5556687
- DOI: 10.1016/j.mam.2016.07.001
Glycan susceptibility factors in autism spectrum disorders
Abstract
Idiopathic autism spectrum disorders (ASDs) are neurodevelopmental disorders with unknown etiology. An estimated 1:68 children in the U.S. are diagnosed with ASDs, making these disorders a substantial public health issue. Recent advances in genome sequencing have identified numerous genetic variants across the ASD patient population. Many genetic variants identified occur in genes that encode glycosylated extracellular proteins (proteoglycans or glycoproteins) or enzymes involved in glycosylation (glycosyltransferases and sulfotransferases). It remains unknown whether "glycogene" variants cause changes in glycosylation and whether they contribute to the etiology and pathogenesis of ASDs. Insights into glycan susceptibility factors are provided by studies in the normal brain and congenital disorders of glycosylation, which are often accompanied by ASD-like behaviors. The purpose of this review is to present evidence that supports a contribution of extracellular glycans and glycoconjugates to the etiology and pathogenesis of idiopathic ASDs and other types of pervasive neurodevelopmental disorders.
Keywords: Autism; Autism spectrum disorders; Brain extracellular matrix; Dystroglycanopathies; Glycans; Glycosaminoglycans; Glycosylation; Glycosyltransferase; Polysialic acid; Proteoglycans.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures


Similar articles
-
The genetic architecture of autism spectrum disorders (ASDs) and the potential importance of common regulatory genetic variants.Sci China Life Sci. 2015 Oct;58(10):968-75. doi: 10.1007/s11427-012-4336-5. Sci China Life Sci. 2015. PMID: 26335735
-
Molecular Functions of Glycoconjugates in Autophagy.J Mol Biol. 2016 Aug 14;428(16):3305-3324. doi: 10.1016/j.jmb.2016.06.011. Epub 2016 Jun 23. J Mol Biol. 2016. PMID: 27345664 Free PMC article. Review.
-
Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders.Brain Res Bull. 2017 Mar;129:82-90. doi: 10.1016/j.brainresbull.2016.10.006. Epub 2016 Oct 12. Brain Res Bull. 2017. PMID: 27743928 Review.
-
ERK/MAPK signaling and autism spectrum disorders.Prog Brain Res. 2018;241:63-112. doi: 10.1016/bs.pbr.2018.09.008. Epub 2018 Nov 1. Prog Brain Res. 2018. PMID: 30447757 Review.
-
Preface.Methods Enzymol. 2017;597:xv-xix. doi: 10.1016/S0076-6879(17)30318-X. Methods Enzymol. 2017. PMID: 28935114 No abstract available.
Cited by
-
Unveiling promising drug targets for autism spectrum disorder: insights from genetics, transcriptomics, and proteomics.Brief Bioinform. 2024 May 23;25(4):bbae353. doi: 10.1093/bib/bbae353. Brief Bioinform. 2024. PMID: 39038939 Free PMC article.
-
The genetic landscape of autism spectrum disorder in the Middle Eastern population.Front Genet. 2024 Mar 20;15:1363849. doi: 10.3389/fgene.2024.1363849. eCollection 2024. Front Genet. 2024. PMID: 38572415 Free PMC article.
-
MAN2A2-related glycosylation defects in autism and cognitive delay.Sci Rep. 2025 Jul 8;15(1):24471. doi: 10.1038/s41598-025-09400-5. Sci Rep. 2025. PMID: 40628855 Free PMC article.
-
Glycosylation Pathways Targeted by Deregulated miRNAs in Autism Spectrum Disorder.Int J Mol Sci. 2025 Jan 17;26(2):783. doi: 10.3390/ijms26020783. Int J Mol Sci. 2025. PMID: 39859496 Free PMC article.
-
Lowered GnT-I Activity Decreases Complex-Type N-Glycan Amounts and Results in an Aberrant Primary Motor Neuron Structure in the Spinal Cord.J Dev Biol. 2024 Aug 16;12(3):21. doi: 10.3390/jdb12030021. J Dev Biol. 2024. PMID: 39189261 Free PMC article.
References
-
- Amado M, Almeida R, Carneiro F, Levery SB, Holmes EH, Nomoto M, et al. A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem. 1998;273(21):12770–12778. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fifth. Arlington, VA: 2013.
-
- Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders–Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. Morb Mortal Wkly Rep Surveill Summ. 2012;61(3):1–19. - PubMed